To date, ACAD9 deficiency, known as a recessive neuromuscular disease, is often characterized by early symptoms and even severe neonatal clinical signs such as cardiomyopathy and neurological and liver dysfunctions. This evidence concerns the gene ACAD9 and Decreased liver function.